Video & Webinars

The Burden of Cognitive Impairment in MS, ECTRIMS 2022 BMS-sponsored Symposium, highlights the importance of early awareness of cognitive impairment (CI), the impact to activities of daily living in patients with MS, the association of CI with MRI alterations and brain atrophy. 𝗙𝗼𝗿 𝗛𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 𝗣𝗿𝗼𝗳𝗲𝘀𝘀𝗶𝗼𝗻𝗮𝗹𝘀 𝗼𝗻𝗹𝘆. 𝗧𝗵𝗶𝘀 𝘀𝘆𝗺𝗽𝗼𝘀𝗶𝘂𝗺 𝘄𝗮𝘀 𝗼𝗿𝗴𝗮𝗻𝗶𝘀𝗲𝗱 𝗮𝗻𝗱 𝗳𝘂𝗻𝗱𝗲𝗱 𝗯𝘆 𝗕𝗿𝗶𝘀𝘁𝗼𝗹 𝗠𝘆𝗲𝗿𝘀 𝗦𝗾𝘂𝗶𝗯𝗯. 𝗕𝗠𝗦 𝗺𝗲𝗱𝗶𝗰𝗶𝗻𝗲𝘀 𝗮𝗻𝗱/𝗼𝗿 𝗽𝗿𝗼𝗱𝘂𝗰𝘁 𝗶𝗻𝗳𝗼𝗿𝗺𝗮𝘁𝗶𝗼𝗻 𝗺𝗮𝘆 𝗯𝗲 𝗱𝗶𝘀𝗰𝘂𝘀𝘀𝗲𝗱. 𝗜𝗠𝗠-𝗚𝗕-𝟮𝟯𝟬𝟬𝟯𝟵𝟬 𝗦𝗲𝗽𝘁 𝟮𝟯.

Brain Preservation and Cognition in MS, a BMS-promotional Symposium Charcot 2022, highlights new MRI biomarkers of brain atrophy, the importance of early intervention on cognitive outcomes in MS and the role of advanced therapies in MS. 𝗙𝗼𝗿 𝗛𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 𝗣𝗿𝗼𝗳𝗲𝘀𝘀𝗶𝗼𝗻𝗮𝗹𝘀 𝗼𝗻𝗹𝘆. 𝗧𝗵𝗶𝘀 𝘀𝘆𝗺𝗽𝗼𝘀𝗶𝘂𝗺 𝘄𝗮𝘀 𝗼𝗿𝗴𝗮𝗻𝗶𝘀𝗲𝗱 𝗮𝗻𝗱 𝗳𝘂𝗻𝗱𝗲𝗱 𝗯𝘆 𝗕𝗿𝗶𝘀𝘁𝗼𝗹 𝗠𝘆𝗲𝗿𝘀 𝗦𝗾𝘂𝗶𝗯𝗯. 𝗕𝗠𝗦 𝗺𝗲𝗱𝗶𝗰𝗶𝗻𝗲𝘀 𝗮𝗻𝗱/𝗼𝗿 𝗽𝗿𝗼𝗱𝘂𝗰𝘁 𝗶𝗻𝗳𝗼𝗿𝗺𝗮𝘁𝗶𝗼𝗻 𝗺𝗮𝘆 𝗯𝗲 𝗱𝗶𝘀𝗰𝘂𝘀𝘀𝗲𝗱. 𝗜𝗠𝗠-𝗚𝗕-𝟮𝟯𝟬𝟬𝟯𝟵𝟬 𝗦𝗲𝗽𝘁 𝟮𝟯.

The overall survival of patients with chronic lymphocytic leukemia (CLL) has improved significantly over the years; however, the clinical…

Adults at Risk of Infectious Diseases: Understanding Prevention Options and Gaps. This integrated symposium took place on 17th April 2023…

Prof. Alexander Röth (Chair), Prof. Wilma Barcellini, Prof. Josephine Vos and Prof. Bernd Jilma, will discuss about the evolving treatment paradigm in cold agglutinin disease (CAD): challenges and opportunities for optimal management.

An innovative session highlighting patient-focused decision-making and a dynamic debate on current 2L DLBCL treatment options.

This webinar takes a retrospective look at the use of monoclonal antibody biosimilars in the treatment of breast cancer.

Join us for an interdisciplinary expert roundtable discussion to gain a deeper understanding of emerging data from EULAR 2023 and real-world evidence with biosimilars. Joined by Rheumatology experts Xenofon Baraliakos and Muhammad Nisar, and Gastroenterolog expert Fraser Cummings.